CDT Equity (CDT) EPS (Basic) (2022 - 2026)
CDT Equity's (CDT) quarterly EPS (Basic) came in at -$55.53 in Q1 2026, up 99.85% YoY from -$27.78 in Q1 2025, and up 99.07% on a QoQ basis from -$5988.0 in Q4 2025.
CDT Equity (CDT) EPS (Basic) (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has 5 years of EPS (Basic) data on file, last reported at -$55.53 in Q1 2026.
- Quarterly EPS (Basic) rose 99.85% year-over-year to -$55.53 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$509.95 (up 99.75% YoY) and the FY2025 annual result came in at -$11779.0, up 98.08% from the prior year.
- EPS (Basic) grew to -$55.53 in Q1 2026, from -$5988.0 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $140702.0 in Q4 2022 to a low of -$1.7 million in Q1 2024.
- A 5-year average of -$166067.8 and a median of -$30863.6 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) surged 171.15% — and 2024, when it sank 2956.66%.
- Tracing CDT's EPS (Basic) over 5 years: stood at $140702.0 in 2022, then plunged by 130.33% to -$42681.8 in 2023, then plunged by 654.34% to -$321965.5 in 2024, then jumped by 98.14% to -$5988.0 in 2025, then surged by 99.07% to -$55.53 in 2026.
- The last three EPS (Basic) figures came in at -$55.53 (Q1 2026), -$5988.0 (Q4 2025), and -$3335.6 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 0.18 |
| 10 | CDT Equity | 1.61 Mn | 1.61 Mn | - | -8.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -62.13 |
| Mar 31, 2026 | -55.53 |
| Dec 31, 2025 | -5,987.99 |
| Sep 30, 2025 | -3,335.64 |
| Jun 30, 2025 | -10,940.22 |
| Mar 31, 2025 | -36,215.38 |
| Dec 31, 2024 | -321,965.52 |
| Sep 30, 2024 | -224,793.10 |
| Jun 30, 2024 | -218,960.00 |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -42,681.82 |
| Sep 30, 2023 | -30,863.64 |
| Jun 30, 2023 | -343,711.00 |
| Mar 31, 2023 | 60,134.50 |
| Dec 31, 2022 | 140,702.00 |
| Sep 30, 2022 | 41,381.20 |
| Jun 30, 2022 | -23,507.80 |
| Mar 31, 2022 | -84,512.00 |